POLICY ON ALLEGATIONS OF RESEARCH MISCONDUCT

Cognix Press is committed to maintaining academic integrity, ethical research practices, and responsible scholarly publishing. We take allegations of research misconduct seriously and aim to address all concerns fairly, transparently, and confidentially, in accordance with ICMJE and COPE guidelines.

1. Reporting a Concern

Any individual may report a genuine concern regarding possible research misconduct in a manuscript or published work. Concerns should include relevant details or supporting evidence whenever available.

Research misconduct may include plagiarism, fabrication or falsification of data, unethical research practices, inappropriate authorship, manipulation of results, or other serious violations of research integrity (ICMJE and COPE).

2. Preliminary Assessment

All concerns received by Cognix Press will be reviewed initially to determine whether further action is necessary. The review may include examination of the manuscript, publication records, research data, editorial correspondence, and other relevant information (COPE).

3. Investigation

Where a concern warrants further examination, Cognix Press may conduct an investigation or refer the matter to the author's institution, employer, research organization, funding agency, or other appropriate authority (ICMJE and COPE).

Independent experts or members of an appropriate editorial or research-integrity committee may be consulted when required.

4. Right to Respond

Authors or other individuals involved in an allegation will normally be given an opportunity to respond and provide relevant explanations or evidence. Cognix Press will seek to ensure that decisions are based on available evidence rather than allegations alone (COPE).

5. Confidentiality

All allegations and investigations will be handled confidentially to the extent reasonably possible. Information will be shared only with individuals who are directly involved in assessing or resolving the matter, subject to applicable legal and ethical requirements (ICMJE and COPE).

6. Protection from Retaliation

Cognix Press does not tolerate retaliation against individuals who raise genuine concerns in good faith. All parties involved in an investigation are expected to act professionally and respectfully.

7. Actions Following an Investigation

Depending on the circumstances and findings, Cognix Press may take appropriate action, including:

Requesting corrections or clarification

Issuing an editorial or research-integrity notice

Correcting or retracting a published article

Rejecting or suspending consideration of a manuscript

Referring the matter to the relevant institution or authority

The action taken will depend on the nature of the concern and the available evidence (ICMJE and COPE).

8. Unsubstantiated Allegations

An allegation will not be considered a finding of misconduct unless supported by sufficient evidence. Cognix Press will take reasonable care to avoid unfairly damaging the reputation of individuals when allegations are not substantiated (COPE).

9. Record Keeping

Cognix Press will maintain appropriate records relating to allegations, investigations, decisions, and actions taken. Records will be stored securely and handled in accordance with applicable privacy and legal requirements.

10. Commitment to Research Integrity

Cognix Press expects authors, editors, reviewers, and research partners to uphold the principles of honesty, transparency, accountability, and ethical conduct in accordance with ICMJE and COPE principles.

Our goal is to protect the integrity of the scholarly record and maintain the trust of authors, researchers, reviewers, and readers.

Cognix Press reserves the right to review and update this policy periodically in accordance with developments in ICMJE and COPE guidelines, research-ethics standards, publishing practices, and applicable regulations.

PUBLICATION MISCONDUCT POLICY

Cognix Press is committed to publishing research that is honest, original, and ethically conducted. We take any form of publication misconduct seriously and work to maintain the trust of authors, reviewers, and readers, in accordance with ICMJE and COPE guidelines.

Publication misconduct may include plagiarism, duplicate publication, fabricated or falsified data, authorship disputes, manipulation of peer review, undisclosed conflicts of interest, or other unethical publishing practices (ICMJE and COPE).

When a concern is raised, Cognix Press will review it carefully and, when necessary, ask the authors or their affiliated institution for clarification. Appropriate action will be taken when misconduct is confirmed, which may include correction, withdrawal, or retraction of the publication (ICMJE and COPE).

All concerns will be handled fairly and confidentially, and individuals who report genuine concerns in good faith will not be subject to retaliation (COPE).

Cognix Press expects everyone involved in the publishing process to follow high standards of integrity, transparency, and responsible publication ethics, consistent with ICMJE and COPE principles.

COMPLAINTS AND APPEALS POLICY

Cognix Press is committed to treating all authors, reviewers, editors, and readers fairly and respectfully. We provide a clear process for raising complaints and requesting a review of publishing decisions, consistent with ICMJE and COPE guidelines.

Complaints may concern editorial decisions, peer review, publication procedures, delays, communication, or other publishing-related matters. Appeals should clearly explain the reason for requesting a reconsideration and provide relevant information where available (COPE).

Every complaint or appeal will be reviewed impartially and handled confidentially where possible. Cognix Press may seek further information from the relevant parties before reaching a decision (ICMJE and COPE).

Our aim is to resolve concerns in a fair, timely, and transparent manner while continuously improving the quality and integrity of our publishing process, in accordance with ICMJE and COPE principles.

ARCHIVING AND DIGITAL PRESERVATION POLICY

Cognix Press is committed to protecting its published content and ensuring that scholarly articles remain available to researchers and readers for the long term, in accordance with the principles of ICMJE and COPE for maintaining the integrity and continuity of the scholarly record.

To support this commitment, Cognix Press uses the PKP Preservation Network (PKP PN) to preserve published journal content and related metadata. This provides an additional layer of protection for the scholarly record and helps reduce the risk of content being lost due to technical issues or changes to the publishing platform.

Cognix Press makes reasonable efforts to ensure that eligible published content is properly archived through PKP PN and that essential publication information is maintained accurately.

If the Cognix Press website or journal platform becomes temporarily or permanently unavailable, preserved content may continue to be available through the relevant preservation services.

Through this policy, Cognix Press supports long-term digital preservation, reliable access, and the continued availability of scholarly publications.

ARTIFICIAL INTELLIGENCE (AI) AND AUTOMATED TOOLS POLICY

Cognix Press recognises that Artificial Intelligence (AI) and automated tools are increasingly being used in academic writing and publishing. These tools may be used as supporting aids, but their use should always be responsible, transparent, and in accordance with research ethics and ICMJE and COPE guidelines.

Authors may use AI tools for language correction, grammar checking, improving readability, translation, and other similar purposes. However, the authors remain fully responsible for the content, originality, accuracy, and conclusions of their manuscript (ICMJE).

AI tools must not be used to create false data, manipulate research results, generate misleading information, or copy the work of others. If AI has been used substantially in preparing a manuscript, authors should disclose such use wherever required by the journal (ICMJE and COPE).

AI tools cannot be considered authors or co-authors, as they cannot take responsibility for the published work (ICMJE).

Editors and reviewers should use AI tools carefully and must maintain the confidentiality of manuscripts and unpublished information. Manuscript content should not be shared with AI tools where such use may compromise confidentiality or intellectual property (ICMJE and COPE).

Cognix Press reserves the right to ask authors for clarification regarding the use of AI when necessary. Our aim is to encourage the responsible use of technology while protecting research integrity, originality, transparency, and trust in scholarly publishing, consistent with ICMJE and COPE principles.

AUTHORSHIP AND CONTRIBUTORSHIP POLICY

Cognix Press follows the principle that authorship should reflect the actual contribution made by each person to the research work and manuscript. Only those who have made a significant contribution should be included as authors.

Authors may contribute through conceptualising the study, conducting the research, collecting or analysing data, interpreting the findings, drafting the manuscript, or critically revising the work. Every author should review and approve the final manuscript and agree to its submission or publication.

The corresponding author should coordinate with all co-authors during the submission and publication process and ensure that there is agreement regarding the authorship list.

People who have supported the work but do not meet the requirements for authorship may be recognised in the Acknowledgements section, with their permission.

Cognix Press does not encourage honorary, guest, or ghost authorship. Any addition, removal, or change in the order of authors after submission should be properly explained and agreed upon by all authors.

If an authorship dispute arises, Cognix Press may seek clarification from the authors or request the concerned institution to assist in resolving the matter.

Cognix Press aims to maintain fairness, transparency, and accountability in all authorship and contributorship matters.

Open Access Statement

Cognix Press follows an open access publishing model. All published articles are freely available online to readers immediately after publication, without subscription or access fees.

Authors retain the copyright of their work and grant Cognix Press the right to publish and distribute the article.

Unless otherwise stated, articles are published under the Creative Commons Attribution–NonCommercial (CC BY-NC) 4.0 International License. Readers may access, share, and reuse the published work for non-commercial purposes, provided appropriate credit is given to the original authors and source.

Cognix Press is committed to free access, author rights, responsible reuse, and transparency in scholarly publishing.

CORRECTION, RETRACTION, WITHDRAWAL AND POST-PUBLICATION DISCUSSION POLICY

Cognix Press aims to keep the published scholarly record accurate, reliable, and transparent. If an issue is identified after publication, we will review it carefully and take suitable action in accordance with relevant Committee on Publication Ethics (COPE) principles and, where applicable, International Committee of Medical Journal Editors (ICMJE) recommendations.

Correction: Minor or significant errors that do not affect the overall validity of the work may be corrected through a published correction notice.

Retraction: An article may be retracted if its findings are found to be unreliable or if serious issues such as plagiarism, misconduct, or major ethical concerns are confirmed. Retraction decisions will follow relevant COPE guidance and applicable ICMJE recommendations.

Withdrawal: A manuscript may be withdrawn before publication when there are valid editorial, ethical, legal, or author-related reasons. Where applicable, withdrawal procedures will be consistent with relevant COPE principles.

Post-Publication Discussion: Readers and researchers may raise genuine, evidence-based concerns about published articles. Authors may be invited to respond when appropriate. For biomedical and health-related publications, relevant ICMJE recommendations concerning post-publication corrections, concerns, and retractions will also be considered.

Any correction, retraction, or withdrawal will be clearly indicated and linked to the original publication where possible.

Cognix Press is committed to fairness, transparency, and maintaining the integrity of the scholarly record in accordance with applicable COPE principles and ICMJE recommendations.

DATA SHARING AND REPRODUCIBILITY POLICY

Cognix Press encourages authors to share research data, materials, protocols, and other supporting information whenever possible. Transparent data sharing helps readers and researchers understand, verify, and reproduce published findings.

Authors should make relevant research data, methods, and supporting materials available through suitable repositories or platforms, where ethical, legal, privacy, and confidentiality requirements permit. Any restrictions on data availability should be clearly explained in the manuscript, including the reason why the data cannot be openly shared.

For biomedical and health-related research, authors should follow applicable International Committee of Medical Journal Editors (ICMJE) recommendations concerning data sharing, transparency, research reporting, and reproducibility.

Authors are responsible for ensuring that shared data are accurate, appropriately documented, ethically obtained, and consistent with the reported research findings. Authors should also respect applicable privacy, consent, intellectual property, and data-protection requirements.

Cognix Press supports transparent, responsible, and reproducible research practices to promote accountability, verification, and trust in the scholarly record.

ETHICS COMMITTEE APPROVAL AND ETHICAL OVERSIGHT POLICY

Cognix Press expects all research to be conducted in accordance with established ethical principles and with respect for the rights, safety, dignity, privacy, and welfare of research participants. This policy is informed by relevant recommendations of the International Committee of Medical Journal Editors (ICMJE) and ethical guidance provided by the Committee on Publication Ethics (COPE).

Research involving human participants, animals, or identifiable personal information should obtain approval from the appropriate Ethics Committee, Institutional Review Board (IRB), Animal Ethics Committee, or equivalent authorised body, where required by applicable institutional, national, or international standards.

Authors should clearly state the ethical approval details in their manuscript, including the name of the approving body and the approval or reference number, where applicable. Where required, authors must also confirm that appropriate informed consent was obtained from research participants or their authorised representatives.

If ethical approval is not applicable to a particular study, authors should provide a clear statement in the manuscript explaining why approval was not required. Authors should ensure that such a determination is consistent with the requirements of the relevant institution, jurisdiction, or applicable ethical guidelines.

Cognix Press may request evidence of ethical approval, informed consent, or other relevant documentation when necessary. Where concerns arise regarding ethical oversight or compliance, Cognix Press may request clarification or supporting documentation and may take appropriate action in accordance with relevant ICMJE and COPE guidance.

Manuscripts that do not meet applicable ethical requirements or cannot provide satisfactory evidence of appropriate ethical oversight may not be considered for publication.

Cognix Press is committed to maintaining ethical, responsible, transparent, and internationally accepted standards of scholarly publishing and research integrity.

INTELLECTUAL PROPERTY AND PERMISSIONS POLICY

Cognix Press respects the intellectual property and creative rights of authors and other content owners. Authors are responsible for ensuring that their submitted work is original and that all sources and materials are used lawfully and appropriately. This policy follows relevant principles of publication ethics outlined by the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).

If a manuscript contains figures, tables, images, photographs, text, or other material belonging to another person or organisation, the author must obtain the necessary permission before publication, unless the material is covered by an appropriate licence, is in the public domain, or its use is permitted under an applicable legal exception.

Authors must give proper credit and citation to all third-party material used in their work. Evidence of permission or licensing may be requested by Cognix Press when required.

If an intellectual property or permissions concern is reported, Cognix Press will review the matter in accordance with applicable publication-ethics principles and relevant guidance from COPE and ICMJE. The Press may request clarification, correction, permission documentation, or other appropriate action where necessary.

Cognix Press aims to promote originality, proper attribution, respect for intellectual property, and the responsible use of published content, in accordance with recognized standards of publication ethics, including those provided by ICMJE and COPE.

PEER REVIEW POLICY

Cognix Press follows a double-blind peer review process, where applicable, to support fair and independent assessment of submitted manuscripts. The identities of authors and reviewers are kept confidential throughout the review process.

Manuscripts are assigned to qualified reviewers who assess the work based on originality, research quality, methodology, clarity, significance, ethical standards, and relevance to the journal. Authors should remove identifying personal and institutional information from the manuscript where required to support anonymous review.

Reviewers are expected to maintain confidentiality, provide objective and constructive feedback, and disclose any actual or potential conflict of interest. Reviewers should decline to review manuscripts where a conflict of interest could affect, or reasonably appear to affect, their impartiality. These practices are consistent with relevant Committee on Publication Ethics (COPE) principles.

The editor considers the reviewers' comments together with the manuscript and other relevant editorial considerations and makes the final editorial decision. Reviewer recommendations inform the decision but do not automatically determine the outcome.

For biomedical and health-related journals, where applicable, Cognix Press also takes into account relevant International Committee of Medical Journal Editors (ICMJE) recommendations concerning peer review, confidentiality, conflicts of interest, and editorial independence.

Cognix Press is committed to maintaining a fair, confidential, transparent, and professional peer review process in accordance with applicable COPE principles, ICMJE recommendations where relevant, and recognized standards of responsible scholarly publishing.

PLAGIARISM, SIMILARITY AND TEXT-REUSE POLICY

Cognix Press expects all submitted manuscripts to be original and appropriately referenced. To support academic integrity, manuscripts submitted for publication may be screened for plagiarism and text similarity using Turnitin or other appropriate similarity-detection tools.

The similarity index should normally be below 20%. However, this percentage is only a general guideline and does not by itself determine whether plagiarism has occurred. The editorial team will review the matched content and its context to determine whether the similarity is acceptable or represents plagiarism, inappropriate text reuse, or inadequate attribution.

Authors must properly cite and acknowledge the work of others and must not copy or reuse substantial portions of previously published or copyrighted material without appropriate attribution or permission. Text recycling, duplicate publication, and other forms of inappropriate text reuse will be assessed in accordance with relevant Committee on Publication Ethics (COPE) principles.

If unacceptable plagiarism or inappropriate text reuse is identified, the manuscript may be returned to the authors for clarification, revision, or correction. In serious cases, the manuscript may be rejected, withdrawn, or retracted, depending on when and how the issue is identified. For biomedical and health-related journals, where applicable, relevant International Committee of Medical Journal Editors (ICMJE) recommendations will also be considered.

Authors are responsible for ensuring that their submissions meet appropriate standards of originality, academic integrity, proper attribution, and responsible text reuse.

Cognix Press is committed to maintaining original, ethical, transparent, and trustworthy scholarly publications in accordance with applicable COPE principles, ICMJE recommendations where relevant, and recognized standards of publication ethics.

PUBLICATION FEES, WAIVERS AND OTHER CHARGES POLICY

Cognix Press is a self-funded publishing house and does not receive financial support or funding from major Indian or international organisations for its publishing activities.

To support the maintenance of the journal, website, editorial systems, digital preservation, DOI services, and other publishing-related activities, Cognix Press may collect an Article Maintenance Fee (AMF) for accepted articles.

Please click here to know about the individual Journal Publication Fee.

Article Submission Charges Submission, editorial processing, and publication of articles are completely free. COGNIX PRESS collects only the Article Maintenance Fee (AMF). For Indian Authors INR 2500  For Overseas Authors: High-Income Countries: 199 USD Upper Middle-Income Countries: 149 USD Lower Middle-Income Countries: 99 USD Low-Income Countries: 65 USD For details on country classification, please refer to the World Bank country classification list.

The applicable fee, if any, will be clearly communicated to authors before publication. Payment of the fee does not influence the peer review process or guarantee acceptance of a manuscript. Editorial decisions are based on the quality, originality, relevance, and ethical standards of the submitted work.

Authors who are unable to pay the applicable fee may contact Cognix Press to discuss a waiver or reduction, where such support is available. Requests for financial assistance will not affect the editorial evaluation of the manuscript.

Cognix Press aims to keep its publication charges transparent, reasonable, and clearly communicated to authors.

REPOSITORY AND SELF-ARCHIVING POLICY

Cognix Press supports the sharing and long-term availability of published research. Authors are encouraged to make their research available through recognised institutional or subject repositories.

Authors may self-archive their published articles in institutional repositories, subject repositories, or personal academic profiles, subject to the applicable copyright and licensing terms.

Where an article is published under Creative Commons Attribution–NonCommercial (CC BY-NC) 4.0 International License, authors and readers may share and reuse the work according to the terms of that licence, with proper attribution.

Authors should ensure that the final published version, citation details, and DOI are correctly identified when depositing the article in a repository.

Cognix Press also supports digital preservation through appropriate archiving services, including the PKP Preservation Network (PKP PN) where applicable.

Our aim is to promote open access, wider dissemination, long-term preservation, and responsible sharing of scholarly research.

REVENUE SOURCES AND BUSINESS MODEL POLICY

Cognix Press operates as a self-funded publishing house. Its primary source of revenue is the Article Maintenance Fee (AMF), where applicable. These fees support essential publishing activities, including editorial operations, peer-review management, website and journal maintenance, DOI services, digital preservation, and administrative costs.

All applicable publication fees are communicated transparently to authors. Payment of an AMF does not guarantee acceptance or influence editorial or peer-review decisions.

Cognix Press maintains a clear separation between financial interests and editorial decision-making. Editorial and peer-review decisions are made independently of publication fees, marketing activities, or other commercial considerations, in accordance with relevant Committee on Publication Ethics (COPE) principles.

For biomedical and health-related journals, where applicable, Cognix Press also follows relevant International Committee of Medical Journal Editors (ICMJE) recommendations concerning editorial independence, financial disclosures, conflicts of interest, and publication ethics.

Our business model is designed to support sustainable journal operations while maintaining transparency, responsible publishing practices, editorial independence, and the integrity of the scholarly record.

ADVERTISING POLICY

Cognix Press does not accept or display advertisements on its journal websites, published articles, or other editorial content. The publishing process is independent of commercial advertising. Editorial decisions, peer review, and publication outcomes are not influenced by advertising or commercial interests, in accordance with the principles of the International Committee of Medical Journal Editors (ICMJE).

Cognix Press does not have any advertising arrangements with external organisations and does not use advertisements as a source of publishing revenue.

Direct Marketing and Manuscript Solicitation Policy

Cognix Press follows a responsible and professional approach to communicating with authors, researchers, editors, and reviewers. Our communication practices are guided by principles of transparency, respect, and ethical publishing, consistent with relevant Committee on Publication Ethics (COPE) guidance.

We may send information about calls for papers, new issues, journal updates, conferences, or other publishing activities through appropriate communication channels. Such communication will be relevant, clear, and not misleading.

Cognix Press does not support aggressive, misleading, or repeated unsolicited solicitation of manuscripts. Authors are free to decide whether or not to submit their work, and submission invitations do not guarantee acceptance or publication.

All editorial and peer review decisions are made independently and are not influenced by marketing activities or author solicitation. Editorial decisions are based on established journal policies and appropriate scholarly and peer-review processes.

Our aim is to maintain respectful, transparent, and ethical communication with the research community while upholding responsible publishing practices and the principles promoted by COPE.

EDITORIAL INDEPENDENCE POLICY

Cognix Press is committed to maintaining editorial independence and ensuring that publishing decisions are based on the quality, originality, relevance, and ethical standards of submitted research.

Editors are responsible for making independent decisions and must not be influenced by authors, reviewers, advertisers, commercial interests, or other external parties. Editors and reviewers must declare and appropriately manage conflicts of interest in accordance with Committee on Publication Ethics (COPE) principles and, where applicable, International Committee of Medical Journal Editors (ICMJE) recommendations.

Peer review and editorial decisions are kept separate from financial and business considerations. Publication or Article Maintenance Fees do not guarantee acceptance or influence editorial decisions.

Cognix Press respects the professional independence of its editors and is committed to fair, transparent, and ethical editorial practices.

UNBIASED, TRANSPARENT, AND ETHICAL EDITORIAL DECISION-MAKING

Cognix Press follows a fair and independent editorial process. Every manuscript is evaluated based on its academic quality, originality, relevance, methodology, and ethical compliance.

Editorial decisions are not influenced by the author’s name, nationality, institution, gender, personal background, or financial status. Editors and reviewers are expected to act objectively, declare conflicts of interest, and follow the ethical principles and guidelines of the Committee on Publication Ethics (COPE).

Peer review is conducted confidentially, with reviewers expected to provide honest, respectful, and constructive assessments. For applicable biomedical and health-related manuscripts, Cognix Press follows relevant International Committee of Medical Journal Editors (ICMJE) recommendations on authorship, ethical conduct, conflicts of interest, and publication practices.

Article Maintenance Fees or other publication charges have no role in editorial decisions and do not guarantee acceptance.

Cognix Press is committed to maintaining integrity, transparency, fairness, and accountability throughout the editorial and publication process.

SPECIAL ISSUES AND GUEST EDITORS POLICY

Cognix Press may publish Special Issues on specific and relevant research topics to promote focused scholarly discussion and academic contribution.

Guest Editors are selected based on their subject expertise, research experience, and academic standing. They must comply with the journal’s editorial and ethical standards and follow the relevant principles and guidelines of the Committee on Publication Ethics (COPE).

All manuscripts submitted to a Special Issue undergo the journal’s standard peer review process. Guest Editors must remain impartial, declare any conflicts of interest, and maintain confidentiality. They must not influence peer review or editorial decisions due to personal or professional relationships with authors.

Final publication decisions remain subject to the journal’s editorial policies, standards, and research integrity requirements. Cognix Press is committed to managing Special Issues with fairness, transparency, academic quality, and research integrity.

DOI AND PERSISTENT IDENTIFIERS POLICY

Cognix Press assigns Digital Object Identifiers (DOIs) to eligible published articles to provide a permanent and reliable link to the scholarly record.

Each DOI is assigned to a specific publication and should be included in the article, citation information, and relevant online records. Authors are expected to use the correct DOI when citing their published work.

Cognix Press maintains accurate article metadata, author details, publication information, and DOI records and updates them when necessary.

Once assigned and registered, a DOI is intended to remain a persistent identifier for the published work, even if the journal website or article location changes.

Cognix Press is committed to maintaining accurate, stable, and long-term identification and access to published research.

PUBLICATION SCHEDULE AND FREQUENCY POLICY

Cognix Press publishes content 3–5 times per week, depending on editorial requirements. Research and special publications may follow a separate schedule.

All content is reviewed for accuracy, originality, quality, and clarity before publication. Schedules may change when additional review or revisions are needed.

Quality and reader value always come before publishing frequency.

PUBLICATION ETHICS POLICY

Cognix Press follows the ethical principles and best practices recommended by the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).

We are committed to honest authorship, transparent disclosures, responsible peer review, confidentiality, originality, and research integrity.

Cases involving plagiarism, fabrication, falsification, authorship disputes, conflicts of interest, or other ethical concerns will be handled according to appropriate ICMJE and COPE guidelines.

Cognix Press may issue corrections, expressions of concern, or retractions when necessary to maintain the integrity of the published record.

Reviewer Guidelines and Selection of Reviewers

Cognix Press follows the ethical principles of the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE) in selecting and managing peer reviewers.

Reviewer Selection: Reviewers are selected based on relevant subject expertise, academic experience, independence, and availability. Authors may suggest reviewers, but the final selection rests with the Editor.

Confidentiality: Reviewers must keep manuscripts and all related information confidential and must not use unpublished information for personal or professional advantage (ICMJE; COPE).

Conflict of Interest: Reviewers must disclose any financial, personal, professional, or academic conflict of interest and decline the assignment where appropriate (ICMJE; COPE).

Objective Review: Reviews must be fair, unbiased, constructive, evidence-based, and respectful. Personal criticism of authors is not permitted (COPE).

Research Integrity: Reviewers should alert the Editor to suspected plagiarism, duplicate publication, data fabrication, falsification, or other ethical concerns (COPE).

Timeliness: Reviewers should complete reviews within the agreed timeframe or promptly inform the Editor if they cannot do so (ICMJE; COPE).

Artificial Intelligence: Reviewers must not upload confidential manuscripts or unpublished material to AI tools unless expressly permitted by the journal and confidentiality can be ensured (ICMJE).

Editorial Decision: Reviewer recommendations are advisory; the final decision on publication rests with the Editor-in-Chief or designated Editor (ICMJE).

Cognix Press reserves the right to appoint additional reviewers when necessary to ensure a fair and rigorous editorial decision.

EMBARGO POLICY

Cognix Press follows the ethical principles of ICMJE and COPE regarding the responsible communication of research before publication.

Confidentiality: Accepted manuscripts must remain confidential until their official publication date.

Embargo: When an embargo is imposed, authors must not publicly share, promote, or distribute the findings before the specified date.

Media Communication: Authors should coordinate press releases and media announcements with the journal when an embargo applies.

Exceptions: Exceptions may be considered for legal, regulatory, or important public-health reasons.

Violation: Breaches of an embargo may be investigated and handled according to Cognix Press's publication-ethics procedures and relevant COPE guidance.